Overview
Spongiotic mycosis fungoides, often referred to as spongiotic gingival hyperplasia (SGH), is a rare and complex condition characterized by an exaggerated inflammatory response within the gingival tissues. This condition predominantly affects the attached gingiva of the anterior maxilla, presenting as solitary, erythematous, and exophytic plaques. The pathophysiology remains partially elucidated but is thought to involve local irritants or trauma triggering an aberrant immune response. Clinical recognition is crucial for differentiating SGH from other gingival hyperplasias and reactive lesions, as accurate diagnosis guides appropriate management strategies. Treatment approaches vary, including surgical excision, topical corticosteroids, and laser therapy, each with varying outcomes in terms of recurrence rates and patient outcomes.
Pathophysiology
The etiopathogenesis of spongiotic gingival hyperplasia (SGH) remains an area of ongoing investigation, with current hypotheses suggesting an exaggerated inflammatory response as a key factor. Recent immunohistochemical studies [PMID:41273749] indicate that local irritants or minor traumas might trigger this response, leading to the characteristic histopathological features observed in SGH. These features include acanthosis, spongiosis, and a dense inflammatory infiltrate within the lamina propria, indicative of an intense immune reaction at the epithelial-connective tissue interface. The involvement of congested capillaries further supports the notion of an inflammatory cascade exacerbated by potential antigenic stimuli. Understanding these mechanisms is crucial for developing targeted therapeutic interventions aimed at modulating the inflammatory process rather than merely addressing the clinical manifestations.
Clinical Presentation
Spongiotic gingival hyperplasia typically manifests clinically as an asymptomatic, solitary lesion, predominantly affecting the attached gingiva of the anterior maxilla. Patients often present with erythematous, exophytic plaques that exhibit a smooth to papillary surface texture [PMID:41273749]. The clinical presentation can vary slightly among cases, reflecting the condition's heterogeneity. For instance, an 18-year-old female reported asymptomatic gingival redness and bleeding, accompanied by gingival recession, edema, and erythema specifically on the buccal gingiva adjacent to maxillary canines [PMID:41832607]. Similarly, an 11-year-old boy presented with a distinct bright-red, granular enlargement affecting the marginal and attached gingiva near specific teeth [PMID:41755451]. These cases highlight the variability in lesion localization and appearance, underscoring the importance of a thorough clinical examination to identify characteristic features that differentiate SGH from other gingival conditions such as inflammatory hyperplasias or reactive lesions.
Diagnosis
Diagnosing spongiotic gingival hyperplasia (SGH) relies heavily on a combination of clinical assessment and histopathological evaluation. Clinically, the presence of an asymptomatic, erythematous, and exophytic plaque with specific gingival involvement is suggestive of SGH [PMID:41273749]. Utilizing an operating microscope (OM) can provide detailed visualization of the gingival surface irregularities, superficial vascular changes, and exudative phenomena, aiding in distinguishing SGH from other forms of gingival hyperplasia [PMID:41832607]. Histopathological analysis is definitive, revealing characteristic features such as acanthosis, spongiosis, exocytosis, and a dense inflammatory infiltrate within the lamina propria, alongside congested capillaries at the epithelium-connective tissue interface [PMID:41832607]. These findings are crucial for confirming the diagnosis and differentiating SGH from other gingival pathologies, emphasizing the need for a multidisciplinary approach involving periodontists and pathologists for accurate identification.
Differential Diagnosis
When encountering a patient with symptoms suggestive of spongiotic gingival hyperplasia (SGH), it is essential to consider and rule out other potential gingival conditions to ensure accurate diagnosis. Common differential diagnoses include various forms of inflammatory hyperplasias, such as those associated with chronic periodontitis, pemphigoid, and other reactive lesions [PMID:41755451]. These conditions can present with similar clinical features such as gingival swelling, erythema, and bleeding, necessitating a thorough clinical examination and possibly additional diagnostic tools like histopathology. The presence of specific clinical features, such as the characteristic spongiotic pattern and dense inflammatory infiltrate noted histopathologically, is critical in distinguishing SGH from these alternatives. Clinicians should maintain a high index of suspicion and employ comprehensive diagnostic protocols to exclude other etiologies effectively.
Management
The management of spongiotic gingival hyperplasia (SGH) encompasses a range of therapeutic approaches, each with varying efficacy and recurrence rates. Surgical excision remains a primary treatment modality, aimed at removing the affected tissue to prevent further progression and recurrence [PMID:41273749]. However, outcomes following surgical intervention show significant variability, with reported recurrence rates ranging from 0% to over 60%, highlighting the need for meticulous surgical technique and postoperative care. In addition to surgical intervention, medical management strategies include the use of topical corticosteroids like clobetasol propionate, which can be prescribed during exacerbation periods to control inflammation and symptoms [PMID:41832607]. Oral hygiene instructions and regular dental prophylaxis are also integral components of management, as emphasized in the case of an 18-year-old patient monitored every four months with supportive care [PMID:41832607]. Emerging minimally invasive techniques, such as the use of an 808 nm high-power diode laser in continuous-wave mode, have shown promising results, achieving excellent hemostasis, preservation of gingival contour, and complete clinical healing without recurrence at follow-up periods of up to four months [PMID:41755451]. These advancements underscore the evolving landscape of SGH treatment, offering alternatives that may reduce recurrence rates and improve patient outcomes.
Prognosis & Follow-up
The prognosis of spongiotic gingival hyperplasia (SGH) varies significantly based on several factors including the surgical technique employed, characteristics of the lesion, patient-specific factors, and adherence to follow-up protocols. Meta-analyses aiming to synthesize evidence on pooled recurrence rates highlight the substantial variability in outcomes [PMID:41273749]. Factors such as meticulous surgical excision, postoperative care, and regular monitoring play crucial roles in determining long-term success. For instance, a patient monitored over two years post-diagnosis and management remained stable, underscoring the importance of consistent follow-up [PMID:41832607]. Additionally, various laser modalities, including CO2 and Nd:YAG lasers, along with photodynamic therapy, have demonstrated complete or near-complete remission with no recurrence during follow-up periods ranging from 5 to 24 months [PMID:41755451]. These findings suggest that advanced minimally invasive techniques may offer improved prognoses, though long-term studies are needed to establish definitive guidelines. Regular follow-up appointments, typically scheduled every 3-6 months initially, are essential to monitor for recurrence and manage any emerging symptoms effectively.
Key Recommendations
Given the variability in treatment outcomes and the current lack of comprehensive evidence-based guidelines for spongiotic gingival hyperplasia (SGH), several key recommendations emerge to improve clinical management and reduce recurrence rates:
These recommendations aim to standardize clinical practice, enhance patient outcomes, and guide future research towards more definitive management protocols for SGH. (Evidence: Expert opinion based on synthesized clinical evidence [PMID:41273749, PMID:41832607, PMID:41755451])
References
1 Lorenzo-Pouso AI, Pérez-Jardón A, González-González A, Ibáñez-Lafuente-de-Mendoza I, Caponio VC, Chauca-Bajaña LA et al.. Recurrence of localized juvenile spongiotic gingival hyperplasia following surgical excision: A systematic review and meta-analysis. Medicina oral, patologia oral y cirugia bucal 2026. link 2 Medeiros YL, Neto JBC, Alves FA. Operating Microscope in the Analysis of Localized Juvenile Spongiotic Gingival Hyperplasia. Oral diseases 2025. link 3 de Arruda JAA, Sampaio GC, Drumond VZ, Abreu LG, de Andrade BAB, Mesquita RA. Spongiotic Gingival Hyperplasia Treated With an 808-nm High-Power Diode Laser: A Case Report and Literature Review. Lasers in surgery and medicine 2026. link